Accumulating evidence suggests that hepatitis E virus (HEV) infection is an emerging disease in regions where HEV is nonendemic. In France, the prevalence of anti-HEV antibodies in the general population has never been studied. Using blood donors' samples, we have found a prevalence of 3.20%, which is similar to that of other industrialized countries.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1933073 | PMC |
http://dx.doi.org/10.1128/JCM.00235-07 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!